Search hospitals > Iowa > Cedar Rapids
Oncology Associates at Mercy Medical Center
Claim this profileCedar Rapids, Iowa 52403
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
291 reported clinical trials
1 medical researcher
Summary
Oncology Associates at Mercy Medical Center is a medical facility located in Cedar Rapids, Iowa. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Oncology Associates at Mercy Medical Center is involved with conducting 291 clinical trials across 354 conditions. There are 1 research doctors associated with this hospital, such as Deborah W. Wilbur.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Clinical Trials running at Oncology Associates at Mercy Medical Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Colorectal Cancer
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This study is evaluating whether a drug called giredestrant can improve the survival of women with early breast cancer.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Oncology Associates at Mercy Medical Center?
Oncology Associates at Mercy Medical Center is a medical facility located in Cedar Rapids, Iowa. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Oncology Associates at Mercy Medical Center is involved with conducting 291 clinical trials across 354 conditions. There are 1 research doctors associated with this hospital, such as Deborah W. Wilbur.